PositiveID

The subsidiary, called ExcitePCR, will own and complete development of the company's Firefly Dx real-time PCR breadboard prototype pathogen detection system.

The company's revenues were primarily derived from a deferred license fee from Boeing, with the remainder coming from the operations of two recent acquisitions.

Proceeds will go toward the further development and field testing of the Firefly DX system and for general working capital. 

The partners will evaluate GenArraytion's MultiFlex assays for clinical, veterinary, food-and water-borne, and weaponized pathogens.

The company's chairman and CEO said that PositiveID has a sizeable backlog and pipeline of revenue opportunities for 2015. 

PositiveID will issue $4 million in senior secured convertible promissory notes to institutional investor Dominion Capital, the firm announced today.

NEW YORK (GenomeWeb) – PositiveID today announced an agreement with the US Special Operations Command Research, Development, and Acquisition Center to further develop military applications for the company's real-time PCR pathogen detection system, Firefly Dx.

NEW YORK (GenomeWeb) — PositiveID and Ensco have been awarded a SenseNet Program contract for an undisclosed amount from the US Department of the Interior on behalf of the US Department of Homeland Security Science and Technology Directorate, Positive ID said today.

NEW YORK (GenomeWeb) – Agilent Technologies said this week that it has mad an adjustment to its second quarter 2014 GAAP net income.

Pages

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.